Avrobio Inc has a consensus price target of $8.9, established from looking at the 20 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, Wells Fargo, and Wedbush on December 18, 2023, July 13, 2023, and July 12, 2023. With an average price target of $2 between Mizuho, Wells Fargo, and Wedbush, there's an implied 68.42% upside for Avrobio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
12/18/2023 | AVRO | Buy Now | Avrobio | $1.19 | 68.42% | Mizuho | Uy Ear | $5 → $2 | Downgrade | Buy → Neutral | Get Alert |
07/13/2023 | AVRO | Buy Now | Avrobio | $1.19 | 68.42% | Wells Fargo | Yanan Zhu | $2.5 → $2 | Maintains | Overweight | Get Alert |
07/12/2023 | AVRO | Buy Now | Avrobio | $1.19 | 68.42% | Wedbush | David Nierengarten | → $2 | Downgrade | Outperform → Neutral | Get Alert |
03/24/2023 | AVRO | Buy Now | Avrobio | $1.19 | 321.05% | Mizuho | Uy Ear | $6 → $5 | Maintains | Buy | Get Alert |
03/24/2023 | AVRO | Buy Now | Avrobio | $1.19 | 405.26% | Needham | Gil Blum | → $6 | Reiterates | → Buy | Get Alert |
12/08/2022 | AVRO | Buy Now | Avrobio | $1.19 | 236.84% | BTIG | Yun Zhong | → $4 | Upgrade | Neutral → Buy | Get Alert |
05/17/2022 | AVRO | Buy Now | Avrobio | $1.19 | 405.26% | Needham | Gil Blum | $8 → $6 | Maintains | Buy | Get Alert |
05/11/2022 | AVRO | Buy Now | Avrobio | $1.19 | 236.84% | Barclays | Gena Wang | $6 → $4 | Maintains | Overweight | Get Alert |
01/06/2022 | AVRO | Buy Now | Avrobio | $1.19 | 405.26% | Mizuho | Uy Ear | $28 → $6 | Maintains | Buy | Get Alert |
01/05/2022 | AVRO | Buy Now | Avrobio | $1.19 | 405.26% | Barclays | Gena Wang | $22 → $6 | Maintains | Overweight | Get Alert |
01/05/2022 | AVRO | Buy Now | Avrobio | $1.19 | 152.63% | Morgan Stanley | Michael Ulz | $7 → $3 | Maintains | Equal-Weight | Get Alert |
01/05/2022 | AVRO | Buy Now | Avrobio | $1.19 | — | BTIG | Yun Zhong | — | Downgrade | Buy → Neutral | Get Alert |
01/05/2022 | AVRO | Buy Now | Avrobio | $1.19 | 573.68% | Needham | Gil Blum | $28 → $8 | Maintains | Buy | Get Alert |
11/19/2021 | AVRO | Buy Now | Avrobio | $1.19 | 489.47% | Morgan Stanley | Michael Ulz | — | Downgrade | Overweight → Equal-Weight | Get Alert |
10/12/2021 | AVRO | Buy Now | Avrobio | $1.19 | 2005.26% | Morgan Stanley | David Lebowitz | — | Maintains | Overweight | Get Alert |
07/16/2021 | AVRO | Buy Now | Avrobio | $1.19 | 2342.11% | Morgan Stanley | David Lebowitz | — | Maintains | Overweight | Get Alert |
06/15/2021 | AVRO | Buy Now | Avrobio | $1.19 | 1836.84% | BTIG | Yun Zhong | — | Initiates | → Buy | Get Alert |
05/27/2021 | AVRO | Buy Now | Avrobio | $1.19 | 2257.89% | Needham | Gil Blum | — | Maintains | Buy | Get Alert |
05/14/2021 | AVRO | Buy Now | Avrobio | $1.19 | 2510.53% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
The latest price target for Avrobio (NASDAQ: AVRO) was reported by Mizuho on December 18, 2023. The analyst firm set a price target for $2.00 expecting AVRO to rise to within 12 months (a possible 68.07% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Avrobio (NASDAQ: AVRO) was provided by Mizuho, and Avrobio downgraded their neutral rating.
The last upgrade for Avrobio Inc happened on December 8, 2022 when BTIG raised their price target to $4. BTIG previously had a neutral for Avrobio Inc.
The last downgrade for Avrobio Inc happened on December 18, 2023 when Mizuho changed their price target from $5 to $2 for Avrobio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avrobio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avrobio was filed on December 18, 2023 so you should expect the next rating to be made available sometime around December 18, 2024.
While ratings are subjective and will change, the latest Avrobio (AVRO) rating was a downgraded with a price target of $5.00 to $2.00. The current price Avrobio (AVRO) is trading at is $1.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.